How much insulin-like growth factor I (IGF-I) circulates? Impact of standardization on IGF-I assay accuracy

被引:55
作者
Quarmby, V
Quan, C
Ling, V
Compton, P
Canova-Davis, E
机构
[1] Genentech Inc, Dept Bioanalyt Technol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA
[3] Genentech Inc, Dept Analyt Chem, San Francisco, CA 94080 USA
关键词
D O I
10.1210/jc.83.4.1211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a significant systematic difference between the normal range obtained from ethylenediamine tetraacetate plasma samples using the Genentech total insulin-like growth factor I (IGF-I) RIA and normal ranges for other total IGF-I RIAs. To determine whether the quality of the assay standard was the cause of this systematic difference, we analyzed commercially available preparations of recombinant human IGF-I (rhIGF-I) typical of those used as IGF-I immunoassay standards along with our own well characterized rhIGF-I assay standard. For the commercial standards, high performance liquid chromatography-derived purities were low, and some vendor-assigned protein concentrations were inconsistent with values from quantitative amino acid analysis. The Genentech rhIGF-I assay standard was highly pure and quantitatively correct. However, the poor quality of some commercial rhIGF-I preparations was not the primary reason for the systematic discrepancy between the Genentech total IGF-I RIA normal range and most other normal ranges. Most assays for total IGF-I are calibrated against the WHO International Reference Reagent (IRR) for IGF-I Immunoassays (87/ 518). The Genentech total IGF-I RIA is not calibrated against WHO IRR 87/518. The protein content assigned to WHO IRR 87/518 was a consensus value from a multicenter collaborative study. Physicochemical analyses showed that WHO IRR 87/518 is Met(-1)-IGF-I of low purity (44%), and that the assigned protein content is higher than the value determined by quantitative amino acid analysis. Thus, assays that are calibrated against WHO IRR 87/518 will report total IGF-I concentrations in excess of actual values. We believe that calibration against WHO IRR 87/518 is the cause of the systematic discrepancy between the Genentech IGF-I assay normal range and most other normal ranges, and that much of the plasma IGF-I concentration data in the literature are of questionable accuracy.
引用
收藏
页码:1211 / 1216
页数:6
相关论文
共 29 条
[1]   EFFECT OF DIABETES AND ITS CONTROL ON INSULIN-LIKE GROWTH-FACTORS IN THE YOUNG SUBJECT WITH TYPE-I DIABETES [J].
AMIEL, SA ;
SHERWIN, RS ;
HINTZ, RL ;
GERTNER, JM ;
PRESS, CM ;
TAMBORLANE, WV .
DIABETES, 1984, 33 (12) :1175-1179
[2]  
ARGIENTE J, 1993, J CLIN ENDOCR METAB, V77, P1522
[3]  
BANG P, 1994, J ENDOCRINOL, V143, pC1
[4]  
Blum W F, 1994, Growth Regul, V4 Suppl 1, P11
[5]   THE INTERNATIONAL REFERENCE REAGENT FOR INSULIN-LIKE GROWTH FACTOR-I [J].
BRISTOW, AF ;
GOODING, RP ;
DAS, REG .
JOURNAL OF ENDOCRINOLOGY, 1990, 125 (02) :191-197
[6]  
Cohen Pinchas, 1994, Current Opinion in Pediatrics, V6, P462, DOI 10.1097/00008480-199408000-00019
[7]  
Covey T R, 1988, Rapid Commun Mass Spectrom, V2, P249, DOI 10.1002/rcm.1290021111
[8]  
*DIAGN SYST LAB, 1995, DSL5600
[9]   THE COMPOSITION AND DISTRIBUTION OF INSULIN-LIKE GROWTH-FACTORS (IGFS) AND IGF-BINDING PROTEINS (IGFBPS) IN THE SERUM OF GROWTH-HORMONE RECEPTOR-DEFICIENT PATIENTS - EFFECTS OF IGF-I THERAPY ON IGFBP-3 [J].
GARGOSKY, SE ;
WILSON, KF ;
FIELDER, PJ ;
VACCARELLO, MA ;
GUEVARAAGUIRRE, J ;
DIAMOND, FB ;
BAXTER, RC ;
ROSENBLOOM, AL ;
ROSENFELD, RG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06) :1683-1689
[10]   A SENSITIVE RADIOIMMUNOASSAY FOR SOMATOMEDIN-C INSULIN-LIKE GROWTH-FACTOR-I BASED ON SYNTHETIC INSULIN-LIKE GROWTH-FACTOR 57-70 [J].
HINTZ, RL ;
LIU, F ;
CHANG, D ;
SEEGAN, G .
HORMONE AND METABOLIC RESEARCH, 1988, 20 (06) :344-347